US1656784A - Medicament for treating diseases of the stomach and intestines - Google Patents

Medicament for treating diseases of the stomach and intestines Download PDF

Info

Publication number
US1656784A
US1656784A US96943A US9694326A US1656784A US 1656784 A US1656784 A US 1656784A US 96943 A US96943 A US 96943A US 9694326 A US9694326 A US 9694326A US 1656784 A US1656784 A US 1656784A
Authority
US
United States
Prior art keywords
medicament
stomach
intestines
treating diseases
atropine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US96943A
Inventor
Fischer August
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US96943A priority Critical patent/US1656784A/en
Application granted granted Critical
Publication of US1656784A publication Critical patent/US1656784A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534Mentha (mint)

Definitions

  • My invention relates to medicaments for treating diseases of the stomach and intestines and has for its object to provide an improved medicament for this purpose.
  • a medicament which contains methylatropine-bromide mixed with substances having an anaesthetic action, for example '.p-amidobenzoic-acid-etliyl-estcr and oil of peppermint, which medicament. is adapted. not only for use in treating diseases of the stomach and intestines, but also for use in removing trouble in the region of the vegetative nervous system.
  • Methyl-atropine-bromide exercises a soothing action wh1ch is increased by the addition of substances having an anzesthetic action. It is very important that the said atropine preparation is characterized in that, on the one hand, it is decidedly less poisonous than the other atropine derivatives and especially so than atropinum sulfuricum which is most frequently used in medicine, and further in that when it is applied in the customary doses usual all those disagreeable poisonous effects which are connected with the use of the sulphate atropine, such as e. g. accommodation troubles, severe dryness in the neck, thirst, are entirely absent.
  • the anaesthetizing components in the combination are so selected as to dose and chemical composition that, as my tests have shown, no inflammation of the sensitive mucous membrane is caused, and poisoning eftects are quite impossible with the doses proposed by me.
  • the local anaesthetic action is made up of three components: firstly methyl-atropine-bromide, as is also the case with the sulphate atropine, exerts a slight local anaesthetic action quite apart from the fact that central anal esic effects are especially peculiar to it. econdly the intended local anaesthesia is produced especially by the almost insoluble p-amido-benzoic-acid- Application fied March 24, 1926. Serial No. 96,943.
  • a medicament for the purpose described, comprisin methyl-atropine-bromide mixed with p-ami o-benzoic-acid-ethyl-ester and oil of peppermint.
  • a medicament in tablet form for the purpose described, comprising 0.5 milligram methylatropine-bromide, 0.1 gr. amidobenzoicacid-ethyl-ester, drop of oil of peppermint and a neutral filling material.

Description

it "g'". u i (it Jana UNITED STATES PATENT oFFIcE.
AUGUST FISCHER, OF BERN, SWITZERLAND.
No Drawing.
My invention relates to medicaments for treating diseases of the stomach and intestines and has for its object to provide an improved medicament for this purpose.
According to this invention there is pro vided a medicament which contains methylatropine-bromide mixed with substances having an anaesthetic action, for example '.p-amidobenzoic-acid-etliyl-estcr and oil of peppermint, which medicament. is adapted. not only for use in treating diseases of the stomach and intestines, but also for use in removing trouble in the region of the vegetative nervous system.
Methyl-atropine-bromide exercises a soothing action wh1ch is increased by the addition of substances having an anzesthetic action. It is very important that the said atropine preparation is characterized in that, on the one hand, it is decidedly less poisonous than the other atropine derivatives and especially so than atropinum sulfuricum which is most frequently used in medicine, and further in that when it is applied in the customary doses usual all those disagreeable poisonous effects which are connected with the use of the sulphate atropine, such as e. g. accommodation troubles, severe dryness in the neck, thirst, are entirely absent.
The anaesthetizing components in the combination are so selected as to dose and chemical composition that, as my tests have shown, no inflammation of the sensitive mucous membrane is caused, and poisoning eftects are quite impossible with the doses proposed by me. The local anaesthetic action is made up of three components: firstly methyl-atropine-bromide, as is also the case with the sulphate atropine, exerts a slight local anaesthetic action quite apart from the fact that central anal esic effects are especially peculiar to it. econdly the intended local anaesthesia is produced especially by the almost insoluble p-amido-benzoic-acid- Application fied March 24, 1926. Serial No. 96,943.
ethylnster. To these actions there is added, thirdly, the slightly anaesthetizing, hyperzemizing and simultaneously disinfecting eitect of oil of peppermint.
These three substances are made up in tablet form together with the usual neutral filling materials, and the tablets are so dosed that each contains as effective constituent parts 0.5 milligram atropinum-methyl-bromatum, 0.1 gr. amido benzoic-acid-ethylester, and drop of oil of eppermint.
These tablets can be used reliably and in many ways with respect to alleviating pain, limiting secretion, diminishing hypertonus and hyperperistaltic of the stomach, the
sovereign spasmolytic action on the stomach intestines and gall-bladder and other organs with smooth muscles, and the stimulating action on the peristalitic of the intestinal canal, and their action makes the same an exceedingly valuable medicament which is certainly superior to atropinun'i sulfuricum in the therapy of abdominal diseases, particularly because the new medicament has been found to be considerably less poisonous than the sulphate atropine and it is quite free from disagreeable accompanying effects when used 1n doses that come into question therapeutically.
I claim:
1. As a new article of manufacture, a medicament, for the purpose described, comprisin methyl-atropine-bromide mixed with p-ami o-benzoic-acid-ethyl-ester and oil of peppermint.
2. As a new article of manufacture, a medicament in tablet form, for the purpose described, comprising 0.5 milligram methylatropine-bromide, 0.1 gr. amidobenzoicacid-ethyl-ester, drop of oil of peppermint and a neutral filling material.
Signed at Bern, this 10th day of March, 1926.
DR. MED. AUGUST FISCHER.
US96943A 1926-03-24 1926-03-24 Medicament for treating diseases of the stomach and intestines Expired - Lifetime US1656784A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US96943A US1656784A (en) 1926-03-24 1926-03-24 Medicament for treating diseases of the stomach and intestines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96943A US1656784A (en) 1926-03-24 1926-03-24 Medicament for treating diseases of the stomach and intestines

Publications (1)

Publication Number Publication Date
US1656784A true US1656784A (en) 1928-01-17

Family

ID=22259857

Family Applications (1)

Application Number Title Priority Date Filing Date
US96943A Expired - Lifetime US1656784A (en) 1926-03-24 1926-03-24 Medicament for treating diseases of the stomach and intestines

Country Status (1)

Country Link
US (1) US1656784A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2628185A (en) * 1949-04-01 1953-02-10 Lewenstein Mozes Juda Analgesic compounds and compositions
US2830930A (en) * 1955-08-08 1958-04-15 Jr Allen M Olinger Parenteral dental local anesthetic solutions containing an alkantheline

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2628185A (en) * 1949-04-01 1953-02-10 Lewenstein Mozes Juda Analgesic compounds and compositions
US2830930A (en) * 1955-08-08 1958-04-15 Jr Allen M Olinger Parenteral dental local anesthetic solutions containing an alkantheline

Similar Documents

Publication Publication Date Title
Aronson Meyler's side effects of analgesics and anti-inflammatory drugs
Young Conditioning treatment of enuresis
WO2020057029A1 (en) Compatible composition of masticinic acid and myrrh terpene, preparation method therefor, and use thereof
CN110548077B (en) Pharmaceutical composition for treating chronic pharyngitis and preparation method and application thereof
Murray Treatment of essential tremor with propranolol.
US1656784A (en) Medicament for treating diseases of the stomach and intestines
CN105796654B (en) Traditional Chinese medicine composition for treating diarrhea-predominant irritable bowel syndrome, navel patch and application
JPH0473413B2 (en)
Ananth et al. Benztropine psychosis
JP2020500915A (en) Phenytoin for local action for use in treating peripheral neuropathic pain
Wali et al. A prospective, randomized, controlled trial study of comparison of two techniques for laryngeal mask airway insertion
CN103432518B (en) A kind of externally-applied medicinal composition and preparation method thereof for the treatment of traumatic injury, arthromyodynia
Wood et al. Urinary excretion of prednisolone after intrarectal therapy in ulcerative colitis
CN102824511B (en) Miao medicine used for oralcavity and preparation technology
Cushny A Textbook of pharmacology and therapeutics, or, the Action of drugs in health and disease
KR20220122680A (en) Compositions and Therapies for the Treatment of Nausea Reflex
US2990327A (en) Composition and method for treating biliary dyskinesia
CN114984001B (en) Use of glycopyrrolate for the preparation of a medicament for the prevention of nausea and vomiting symptoms
Dukes Corticotrophins and corticosteroids
CN106039019A (en) Traditional Chinese medicinal preparation for treating gastrohelcosis and method for preparing traditional Chinese medicinal preparation for treating gastrohelcosis
CROHN STUDIES IN FRACTIONAL ESTIMATION OF STOMACH CONTENTS. III. EFFECTS OF HYDROCHLORIC ACID THERAPY ON THE ACID TITER OF THE STOMACH DURING DIGESTION. 1
CN105169352A (en) Externally applied traditional Chinese medicinal analgetic for treating pains due to wind-damp arthritis
DE202014005450U1 (en) Lactose-free medicine
US1212888A (en) Mentholated or minted cathartic salts.
Banerji Anti-Emetic Effects of Methylprednisolone with Ramosetron in Gynecologic Laparoscopic Surgeries